mRx-7: A new weapon for cancer

miReven

miReven is a biopharmaceutical company focused on developing mRx-7 as a new cancer therapy. The world of RNA-based therapeutics is an entirely new clinical treatment.

Our Science

mRx-7 is a synthetic small double stranded RNA (dsRNA) chemically modified mimic of microRNA-7 (miR-7) that we have designed, which is a potent inhibitor of…

Investors

miReven welcomes new partnerships. Please contact us for information about investing in our company.

Recent Post

Vivo 50 LITE

Vivo V50 Lite 5G Debuts with Massive 7600mAh Battery and Powerful Processor

Read More
Sony

Sony Halts Xperia 1 VII Sales to Address Technical Issues

Read More
OnePlus

OnePlus Nord CE 5 Launching July 8 in India: Price, Chipset, Camera, Design & More

Read More
Join WhatsApp Group Join Group!